측방유동분석법 시장 : 제품별, 기술별, 용도별, 최종 사용자별, 지역별 예측(-2036년)

Lateral Flow Assays Market by Product (Kits & Reagents, Lateral Flow Readers), Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing), End User, and Geography-Global Forecast to 2036

According to the research report titled, 'Lateral Flow Assays Market by Product (Kits & Reagents, Lateral Flow Readers), Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing), End User, and Geography-Global Forecast to 2036,' the global lateral flow assays (LFA) market is valued at USD 13.7 billion in 2026 and is expected to reach approximately USD 27.4 billion by 2036, at a CAGR of 7.9% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global lateral flow assays market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the lateral flow assays market include increasing demand for rapid diagnostic testing, growing prevalence of infectious diseases, and widespread adoption of point-of-care testing solutions. Additionally, digital and mobile reader technology integration, multiplex detection expansion, home-based testing emphasis, and emerging application development in veterinary diagnostics and food safety are expected to create significant growth opportunities for players operating in the lateral flow assays market.

Market Segmentation

The lateral flow assays market is segmented by product (kits & reagents, lateral flow readers), technique (sandwich assays, competitive assays, multiplex detection assays), application (clinical testing, veterinary diagnostics, food safety & environment testing, drug development & quality testing), end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Product

By product, kits and reagents represent the largest segment in the lateral flow assays market in 2026, attributed to the high volume of diagnostic tests performed globally and the recurring nature of kit and reagent purchases. Digital and mobile lateral flow readers are the fastest-growing product segment, providing quantitative results and eliminating subjectivity associated with visual interpretation. These readers enable data transmission to electronic health records and laboratory information systems, improving workflow efficiency.

Based on Technique

By technique, sandwich assays, competitive assays, and multiplex detection assays represent the key technical approaches in the market. Multiplex lateral flow assays capable of detecting multiple analytes simultaneously are a significant market trend, enabling comprehensive diagnostic evaluation in a single test and improving efficiency while reducing testing costs.

Based on Application

By application, clinical testing is the largest segment, driven by widespread use of rapid diagnostic tests in healthcare settings. Infectious disease testing, including tests for COVID-19, influenza, and other respiratory pathogens, represents the largest sub-segment. Emerging applications in veterinary diagnostics, food safety testing, and drug development are creating new market opportunities. Pregnancy and fertility testing, cardiac marker testing, and cholesterol screening are additional clinical applications driving market growth.

Based on End User

By end user, hospitals and clinics hold the largest share, driven by high volume of diagnostic testing performed in these settings. Home care settings are experiencing rapid growth in lateral flow assay adoption, driven by increasing emphasis on home-based testing and self-diagnostics. Diagnostic laboratories, research institutions, and veterinary clinics represent additional end-user segments.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is expected to hold the largest market share for lateral flow assays, driven by advanced healthcare infrastructure, high healthcare spending, and strong regulatory frameworks. Europe is projected to experience steady growth, driven by supportive regulatory frameworks and adoption of point-of-care testing. Asia-Pacific is emerging as the fastest-growing region, with increasing healthcare spending, improving healthcare infrastructure, and growing awareness of diagnostic testing in countries such as China, India, and Japan.

Key Players

The key players operating in the global lateral flow assays market are Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Biomerieux S.A., QIAGEN N.V., PerkinElmer, Inc., Quidel Corporation, Merck KGAA, and various other regional and emerging manufacturers, among others.

Key Questions Answered in the Report-

• What is the current revenue generated by the lateral flow assays market globally?
• At what rate is the global lateral flow assays market demand projected to grow for the next 7-10 years?
• What are the historical market sizes and growth rates of the global lateral flow assays market?
• What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
• Which segments in terms of product, technique, application, and end user are expected to create major traction for the service providers in this market?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global lateral flow assays market?
• Who are the major players in the global lateral flow assays market? What are their specific service offerings in this market?
• What are the recent strategic developments in the global lateral flow assays market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Lateral Flow Assays Market Assessment -- by Product

• Kits & Reagents
• Lateral Flow Readers

Lateral Flow Assays Market Assessment -- by Technique

• Sandwich Assays
• Competitive Assays
• Multiplex Detection Assays

Lateral Flow Assays Market Assessment -- by Application

• Clinical Testing
• Veterinary Diagnostics
• Food Safety & Environment Testing
• Drug Development & Quality Testing

Lateral Flow Assays Market Assessment -- by End User

• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care
• Research Institutions
• Veterinary Clinics
• Other End Users

Lateral Flow Assays Market Assessment -- by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Assessment
  • 2.3.1. Market Size Estimation
    • 2.3.1.1. Bottom-Up Approach
    • 2.3.1.2. Top-Down Approach
    • 2.3.1.3. Growth Forecast
  • 2.3.2. Market Share Analysis
• 2.4. Assumptions for this Study
• 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

• 4.1. Introduction
• 4.2. Drivers
  • 4.2.1. Benefits of LFA-Based Rapid Tests over Laboratory Tests
  • 4.2.2. Increasing Usage of Home-Based Lateral Flow Assays
  • 4.2.3. Growing Demand for Point-of-Care Testing
  • 4.2.4. Growing Prevalence of Chronic & Infectious Diseases
  • 4.2.5. Growing Acceptance of Smart Devices
• 4.3. Restraints
  • 4.3.1. Variability in Lateral Flow Assay Test Results
• 4.4. Opportunities
  • 4.4.1. Evolving Applications of Lateral Flow Assays
  • 4.4.2. Rising Demand in Food & Beverage Industry
• 4.5. Challenges
  • 4.5.1. Reluctance Toward Changing Diagnostic Practices
  • 4.5.2. Development of Multiplexing Assays

5. Global Lateral Flow Assays Market, by Product

• 5.1. Introduction
• 5.2. Kits & Reagents
• 5.3. Lateral Flow Readers
  • 5.3.1. Digital/Mobile Readers
  • 5.3.2. Benchtop Readers

6. Global Lateral Flow Assays Market, by Technique

• 6.1. Introduction
• 6.2. Sandwich Assays
• 6.3. Competitive Assays
• 6.4. Multiplex Detection Assays

7. Global Lateral Flow Assays Market, by Application

• 7.1. Introduction
• 7.2. Clinical Testing
  • 7.2.1. Infectious Disease Testing
  • 7.2.2. Pregnancy & Fertility Testing
  • 7.2.3. Cardiac Marker Testing
  • 7.2.4. Cholesterol Testing/Lipid Profile
  • 7.2.5. Drug Abuse Testing
  • 7.2.6. Other Clinical Tests
• 7.3. Veterinary Diagnostics
• 7.4. Food Safety & Environmental Testing
• 7.5. Drug Development & Quality Testing

8. Global Lateral Flow Assays Market, by End User

• 8.1. Introduction
• 8.2. Hospitals & Clinics
• 8.3. Diagnostic Laboratories
• 8.4. Home Care Settings
• 8.5. Pharmaceutical & Biotechnology Companies
• 8.6. Other End Users

9. Market, by Geography

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific
• 9.5. Latin America
• 9.6. Middle East & Africa

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Market Share Analysis

11. Company Profiles

• 11.1. Abbott Laboratories
• 11.2. F. Hoffmann-La Roche AG
• 11.3. Becton, Dickinson and Company
• 11.4. Siemens Healthineers AG
• 11.5. Thermo Fisher Scientific, Inc.
• 11.6. Bio-Rad Laboratories, Inc.
• 11.7. bioMerieux S.A.
• 11.8. QIAGEN N.V.
• 11.9. PerkinElmer, Inc.
• 11.10. Quidel Corporation
• 11.11. Merck KGaA
• 11.12. Others

12. Appendix

• 12.1. Questionnaire
• 12.2. Available Customization